IIM
HZNP

INTECH Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

INTECH Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60,182
Closed -$6.96M – 766
2023
Q3 		$6.96M Buy
60,182
+4,660
+8% +$501K 0.1% 209
2023
Q2 		$5.71M Buy
55,522
+9,773
+21% +$1.03M 0.06% 262
2023
Q1 		$4.99M Sell
45,749
-800
-2% -$88.4K 0.04% 377
2022
Q4 		$5.3M Buy
46,549
+5,511
+13% +$458K 0.04% 372
2022
Q3 		$2.54M Sell
41,038
-16,706
-29% -$1.17M 0.02% 415
2022
Q2 		$4.61M Buy
+57,744
New +$5.47M 0.03% 370

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

INTECH Investment Management's HZNP Position: Q4 2023 in Review

INTECH Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 60,182 shares — an estimated $6.96M sold.

INTECH Investment Management first reported a position in HZNP in Q2 2022 and held it in 6 quarters. The position peaked at $6.96M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • INTECH Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • INTECH Investment Management sold 60,182 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.96M.
  • INTECH Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 6 quarters.
  • INTECH Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.96M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on INTECH Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.